Status:
COMPLETED
Investigation of Polymorphisms in Bronchopulmonary Dysplasia In Turkish Population
Lead Sponsor:
Seda Yilmaz Semerci
Conditions:
Bronchopulmonary Displasia
Eligibility:
All Genders
Phase:
NA
Brief Summary
Bronchopulmonary dysplasia (BPD) is a chronic lung disease that affects a ratio of up to 20-30% of infants prematurely born before 30rd week. Delay of starting to speak, cerebral palsy and cognitive d...
Detailed Description
Bronchopulmonary dysplasia is a chronic lung disease that affects a ratio of up to 20-30% of infants prematurely born before 30rd week. Delay of starting to speak, cerebral palsy and cognitive disorde...
Eligibility Criteria
Inclusion
- infants born under 30 gestational week
- infants with bronchopulmonary displasia
Exclusion
- major congenital abnormalities
- lack of data
- parents don't agree with informed consent
Key Trial Info
Start Date :
July 4 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 24 2018
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT03467828
Start Date
July 4 2017
End Date
May 24 2018
Last Update
March 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, Kucukcekmece, Turkey (Türkiye), 34303